• Pivotal China

Pivotal Scientific & CUSABIO

CUSABIO’s facility has been visited and reviewed by Fan Sha our Business Development Manager- Asia, and has been awarded Pivotal Scientific’s stamp of approval logo. For companies to display this logo, the company must have demonstrated the five below competencies during Fan Sha’s visit.

  • First and foremost, quality in their products
  • Excellent customer feedback
  • Excellent customer services
  • Timely delivery rate
  • And additionally, product innovation

In addition to this, CUSABIO is a proud member of the PSL Alliance and enjoys the networking opportunities being part of this research reagent group of companies. To further expand their reach, CUSABIO also has this dedicated page to highlight their key business areas.

To be personally introduced to CUSABIO, please contact a member of the Pivotal Scientific team.

An Introduction to CUSABIO.

CUSABIO is a National High-Tech Enterprise with research, production and sales as one. After 11 years, CUSABIO has become a great partner to researchers across the globe. They are dedicated to providing 60,000+ validated antibodies, 5640+ recombinant proteins, 350+ cytokines and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc.

All kinds of CUSABIO’s products can meet customers’ different demands in various scientific research fields and additionally, they also aim at improving their product quality and service. Their high quality has been guaranteed in published literature in all kinds of famous journals, such as Science, Nature, Cell, Developmental Biology, Molecular Cell, Genes & Development, and so on. Now, their products have been cited by thousands of publications, and hundreds of publications are updating every year. CUSABIO have distributors all around the world so wherever you are, you can always reach their products through local or global distributors.

cusabio logo2

CUSABIO’s Products & Services

Arrange an introduction

Speak to us today